...
首页> 外文期刊>BMC Ophthalmology >Clinical differences between toric intraocular lens (IOL) and monofocal intraocular lens (IOL) implantation when myopia is determined as target refraction
【24h】

Clinical differences between toric intraocular lens (IOL) and monofocal intraocular lens (IOL) implantation when myopia is determined as target refraction

机译:当近视被确定为目标折射时转矩眼内透镜(IOL)和单焦点眼内透镜(IOL)植入的临床差异

获取原文
           

摘要

The aim of this study is to analyze and compare the clinical results of toric intraocular lens (IOL) and monofocal IOL implantation when the target refraction value is -3 diopter (D) in cataract patients with corneal astigmatism??1.5 diopters (D). We performed a retrospective chart review for patients with corneal astigmatism??1.5D who underwent cataract surgery and their target refraction is -3D. 100 eyes (100 patients; monofocal IOL, 60; toric IOL, 40) were enrolled in the current study. Near and distant uncorrected visual acuity (UCVA), corrected VA, spherical equivalent and refractive, corneal astigmatism were evaluated before and after surgery. The near UCVA of the toric IOL group (0.26?±?0.33) after cataract surgery was significantly better than that of the monofocal IOL group (0.48?±?0.32) (p?=?0.030). The distant UCVA of the toric IOL group (0.38?±?0.14) was also significantly better than that of the monofocal IOL group (0.55?±?0.22) (p?=?0.026). Best-corrected visual acuity (p?=?0.710) and mean spherical equivalent (p?=?0.465) did not show significant differences between the toric IOL group and the monofocal IOL group. In the toric IOL group, postoperative refractive astigmatism was ??0.80?±?0.46D and postoperative corneal astigmatism was ??1.50?±?0.62D, whereas the corresponding values in the monofocal IOL group were ??1.65?±?0.77D and ??1.45?±?0.64D; residual refractive astigmatism was significantly lower with toric IOL implantation compared with monofocal IOL implantation (p?=?0.001). There were no postoperative complications. When myopic refraction such as -3D was determined as the target power in patients with corneal astigmatism, toric IOL implantation led to excellent improvement in both near and distant UCVA.
机译:本研究的目的是分析和比较当目标折射值是角膜散疗中的靶折射值 - 3屈光度(d)时的角质眼内透镜(IOL)和单焦型IOL植入的临床结果?&Δ1.5屈光度(d )。我们对角膜散差的患者进行了回顾性的图表评审,&?1.5d接受白内障手术及其目标折射的患者是-3d。 100只眼(100名患者;单焦型IOL,60; Toric IOL,40)注册了目前的研究。在手术前后评估附近和遥远的未矫正视力(UCVA),校正的VA,球形等效和折射,角膜散差异。 Toric IOL组的近UCVA(0.26?±0.33)在白内障手术后明显优于单焦质IOL基团(0.48≤α0.32)(p?= 0.030)。 Toric IOL组的远处UCVA(0.38?±0.14)也明显优于单焦质IOL基团(0.55°+ 0.22)(p?= 0.026)。最佳校正的视力(P?= 0.710)和平均球形等同物(p?= 0.465)在Toric IOL组和单焦型IOL组之间没有显示出显着差异。在Toric IOL组中,术后屈光散光是0.80?±0.46d和术后角膜散差是Δε1.50?±0.62d,而单焦ool组中的相应值为1.65?±0.77D和?? 1.45?±0.64d;与单焦型IOL植入相比,Toric IOL植入量明显降低了残留的折射散光(P?= 0.001)。没有术后并发症。当近视折射如-3D被确定为角膜散光患者的目标能力时,Toric IOL植入导致近乎近的UCVA的优异改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号